The following fields were updated due to additional information: d.10.Device available for eval?: yes.D.10.Returned to manufacturer on: 12/11/2020.H.6.Investigation: bd has received several customer complaints for false positive results, when using bd sars-cov-2 reagents for bd veritor¿ system.The current investigation concerns multiple lots of bd sars-cov-2 reagents for bd veritor¿ system.Bd takes a systematic approach to investigating false positive complaints that are received.This approach involves review of manufacturing batch history records, testing of retention samples, and testing of customer returned samples (if applicable).The batch history records were reviewed and no discrepancies were noted.Functional analysis of retention materials met acceptance criteria.Returned products were received, however the material has passed expiration date and will not be tested.Bd makes no claims on expired products and stability studies have shown the use of expired materials may affect the sensitivity of the assay.Quality was unable to duplicate the customers reported failure mode.Complaint trending review reveals a trend in customer complaints related to false positive results, when using bd sars-cov-2 reagents for bd veritor¿ system.Although the investigation was not confirmed, based on the complaint trend, a corrective and preventive action (capa) was initiated (1878253) to determine root cause(s).Bd point of care will continue to closely monitor for trends associated with false positive or discrepant results when using the kit bd veritor for rapid detection of sars-cov-2.There was no corrective action taken at this time.
|